Trump Just Signed An Executive Order to Reschedule Cannabis, Expand CBD Access

The United States government has taken a significant step towards reclassifying cannabis. On December 18, 2025, President Trump signed an executive order to reschedule cannabis from a Schedule I to a Schedule III controlled substance. This move does not have any impact on the federal status of the plant, but it will make it easier for researchers to study its potential benefits and for companies to develop CBD products.

The reclassification is a result of years of advocacy from medical marijuana patients, researchers, and industry leaders. They have been pushing for a change in the classification of cannabis, arguing that it has therapeutic benefits and should be treated as a legitimate medicine.

The executive order is a significant development in the ongoing debate over cannabis policy in the United States. While the federal government still considers cannabis a Schedule I substance, the move is seen as a step towards greater acceptance and regulation of the plant.

The reclassification will also have implications for the CBD industry, which has been growing rapidly in recent years. CBD products are derived from the cannabis plant and are used for a range of purposes, from pain relief to anxiety treatment.

The Trump administration's decision to reschedule cannabis is a significant victory for advocates of medical marijuana and the CBD industry. However, it is worth noting that the federal government still considers cannabis a Schedule I substance, and the reclassification does not change that.

Sources

[8] Trump Just Signed An Executive Order to Reschedule Cannabis, Expand CBD Access